Skip to main content

Michael R Abern, MD

Associate Professor of Surgery
Office: 40 Duke Medicine Circle, DUMC Box 3707, Durham, NC 27710
Campus Mail: DUMC 200 Trent Drive, DUMC Box 2804, Durham, NC 27710

Education and Training

  • Urologic Oncology Fellow, Surgery, Duke University School of Medicine, 2011 - 2013
  • Urology Resident, Surgery, Rush University Medical Center, 2006 - 2011
  • M.D., Rush University, Medical College, 2006
  • B.S., University of Illinois, 1996

Publications

Fantony, Joseph J., Michael R. Abern, Ajay Gopalakrishna, Richmond Owusu, Kae Jack Tay, Raymond S. Lance, and Brant A. Inman. “Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.” Urol Oncol 33, no. 9 (September 2015): 387.e1-387.e6. https://doi.org/10.1016/j.urolonc.2015.04.014.

Full Text

Ovadia, Aaron E., Martha K. Terris, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Stephen J. Freedland, and Michael R. Abern. “Agent Orange and long-term outcomes after radical prostatectomy.” In Urol Oncol, 33:329.e1-329.e6, 2015. https://doi.org/10.1016/j.urolonc.2015.04.012.

Full Text

Sun, Belinda L., Michael Abern, Steven Garzon, and Suman Setty. “Cystic nephroma/mixed epithelial stromal tumor: a benign neoplasm with potential for recurrence.” Int J Surg Pathol 23, no. 3 (May 2015): 238–42. https://doi.org/10.1177/1066896914563391.

Full Text

Al Rasheed, M Haroon, S. Setty, A. Dudek, and M. Abern. “FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND PAPILLARY RENAL CELL CARCINOMA: CAUSAL LINK?” In Journal of Investigative Medicine, 63:693–693, 2015.

Scholars@Duke

Mendez, Melissa, Mitchell Bassett, Michael Abern, Lionel Banez, Michael Ferrandino, Cary Robertson, Stephen Freedland, et al. “MP14-13 WEIGHING IN ON ACTIVE SURVEILLANCE: IMPACT OF OBESITY ON PATIENT COUNSELING.” In Journal of Urology, Vol. 193. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1016/j.juro.2015.02.875.

Full Text

Wadhwa, Harpreet, Martha Terris, William Aronson, Christopher Kane, Christopher Amling, Matthew Cooperberg, Stephen Freedland, and Michael Abern. “MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT.” In Journal of Urology, Vol. 193. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1016/j.juro.2015.02.1706.

Full Text

Tsivian, Matvey, Melissa Mendez, Michael Abern, Peter Qi, Edward Rampersaud, and Thomas Polascik. “MP59-01 IMPACT OF BLOOD TRANSFUSIONS ON ONCOLOGICAL OUTCOMES OF SURGICALLY TREATED LOCALIZED RENAL CELL CARCINOMA.” In Journal of Urology, Vol. 193. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1016/j.juro.2015.02.2161.

Full Text

Wang, Hsin-Hsiao S., Michael R. Abern, Nicholas G. Cost, David I. Chu, Sherry S. Ross, John S. Wiener, and Jonathan C. Routh. “Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.” J Urol 192, no. 4 (October 2014): 1196–1202. https://doi.org/10.1016/j.juro.2014.04.003.

Full Text

Qi, Peter, Matvey Tsivian, Michael R. Abern, Niccolo M. Passoni, Kathleen F. McGinley, and Thomas J. Polascik. “Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.” Urol Oncol 32, no. 5 (July 2014): 555–60. https://doi.org/10.1016/j.urolonc.2013.11.011.

Full Text

Pages